View drug registration information details.


ItemsRegistration information
ID1616
No1616
Brand NameALISELINISO
IngredientsSELINEXOR 20 MG
Dosage FormTABLET
Primary PackagingBOTTLE
Storage
Shelf Life2 YEARS
Pack Size32 TABLETS/BOTTLE
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsIN COMBINATION WITH BPRTEZOMIB AND DEXAMETHASONE FOR THE TREATMENT OF ADULT PATIENTS WITH MULTIPLE MYELOMA WHO HAVE RECEIVED AT LEAST ONE PRIOR THERAPY, FOR THE TREATMENT OF ADULT PATIENT WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA, NOT OTHERWISE SPECIFIED, INCLUDING DLBCL ARISING FROM FOLLICULLAR LYMPHOMA, AFTER AT LEAST 2 LINES OF SYTEMIC THERAPY
Contraindications
Side Effects
Unit Price
EDL NULL
DescriptionBLUE TABLET
Note
License OwnerLAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY
ManufacturerLAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY
CountryLAOS
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No10 L 1223/24
FDD Registration Date31-OCT-2024
Expiry Date30-OCT-2029

Back to drug list

 
© 2014 ສະຫງວນລິຂະສິດໂດຍ ກົມອາຫານ ແລະ ຢາ, ກະຊວງສາທາລະນະສຸກ, ສປປລາວ.
ຕິດຕໍ່ ກອຢ      ອີເມວ      ເຂົ້າລະບົບ